Clinical Trials in Colorado

Showing 5161-5180 of 18,143 trials

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

NCT03945318

Multicenter study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of BION-1301 in healthy volunteers and adults with IgA Nephropathy (IgAN).

IgA Nephropathy

Novartis Pharmaceuticals103 participantsStarted Apr 2019

Northridge, California, United States • Denver, Colorado, United States • Orlando, Florida, United States +13 more locations

Active Not RecruitingPhase 353 miles

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

NCT05257408

The primary objectives of this study are to evaluate progression-free survival (PFS) by blinded independent central review (BICR) and overall survival (OS) (evaluated independently, as dual primary endpoints) in patients treated with intermittent regimen of Relacorilant in combination with nab-paclitaxel compared with patients treated with nab-paclitaxel monotherapy.

Ovarian NeoplasmFallopian Tube NeoplasmsPeritoneal Neoplasms

Corcept Therapeutics381 participantsStarted Jun 2022

Phoenix, Arizona, United States • Tucson, Arizona, United States • Irvine, California, United States +114 more locations

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

Find Trials by Condition in Colorado

Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia

Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

R3 Delta Ceramic Acetabular System PAS U.S.

Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Tritanium® Primary Acetabular Shell Study

A Phase 1b Study of WU-NK-101 in Combination With Cetuximab